Cardio Diagnostics Holdings, Inc. (CDIO)Healthcare | Biotechnology | Chicago, United States | NasdaqCM
1.96 USD
-0.01
(-0.508%) ⇩
(April 21, 2026, 10:14 a.m.
EDT)
Short-term: ★★★☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:25 a.m. EDT
CDIO is a compelling long-term value trap with deteriorating fundamentals (negative revenue growth, massive losses, negative free cash flow) and a toxic technical setup, despite current low share price relative to its 52-week high; however, the short-term momentum is currently neutral with a slightly negative price forecast, suggesting time-value or caution rather than an immediate scaling opportunity. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.381558 |
| AutoARIMA | 0.381909 |
| AutoETS | 0.381910 |
| AutoTheta | 0.649237 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 80% |
| H-stat | 0.06 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.169 |
| Excess Kurtosis | -0.76 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 9.975 |
| Revenue per Share | 0.008 |
| Market Cap | 5,800,559 |
| Forward P/E | -7.84 |
| Beta | 2.66 |
| Website | https://cdio.ai |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.8413849 |
| Address1 | 311 West Superior Street |
| Address2 | Suite 444 |
| All Time High | 307.5 |
| All Time Low | 0.97 |
| Ask | 2.5 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 86,890 |
| Average Daily Volume3 Month | 3,714,542 |
| Average Volume | 3,714,542 |
| Average Volume10Days | 86,890 |
| Beta | 2.658 |
| Bid | 1.4 |
| Bid Size | 2 |
| Book Value | 3.819 |
| City | Chicago |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.96 |
| Current Ratio | 9.789 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 1.96 |
| Day Low | 1.9232 |
| Debt To Equity | 9.975 |
| Display Name | Cardio Diagnostics |
| Earnings Timestamp End | 1,778,788,800 |
| Earnings Timestamp Start | 1,778,788,800 |
| Ebitda | -6,085,950 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.233 |
| Enterprise To Revenue | 95.457 |
| Enterprise Value | 1,415,142 |
| Eps Forward | -0.25 |
| Eps Trailing Twelve Months | -3.71 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.7759 |
| Fifty Day Average Change | -0.81589985 |
| Fifty Day Average Change Percent | -0.29392266 |
| Fifty Two Week Change Percent | -84.13849 |
| Fifty Two Week High | 17.4 |
| Fifty Two Week High Change | -15.44 |
| Fifty Two Week High Change Percent | -0.88735634 |
| Fifty Two Week Low | 0.97 |
| Fifty Two Week Low Change | 0.99 |
| Fifty Two Week Low Change Percent | 1.0206186 |
| Fifty Two Week Range | 0.97 - 17.4 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,642,170,600,000 |
| Float Shares | 2,833,899 |
| Forward Eps | -0.25 |
| Forward P E | -7.84 |
| Free Cashflow | -3,809,743 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 15 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 1.0 |
| Gross Profits | 14,825 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.08307 |
| Held Percent Institutions | 0.04377 |
| Implied Shares Outstanding | 2,959,469 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,747,094,400 |
| Last Split Factor | 1:30 |
| Long Business Summary | Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, such as concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois. |
| Long Name | Cardio Diagnostics Holdings, Inc. |
| Market | us_market |
| Market Cap | 5,800,559 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_1671478040 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -6,498,167 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 5,830,153 |
| Open | 1.93 |
| Operating Cashflow | -5,726,833 |
| Operating Margins | -411.59552 |
| Payout Ratio | 0.0 |
| Phone | 855 226 9991 |
| Previous Close | 1.97 |
| Price Hint | 4 |
| Price To Book | 0.51322335 |
| Price To Sales Trailing12 Months | 391.26874 |
| Profit Margins | 0.0 |
| Quick Ratio | 8.463 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.00999999 |
| Regular Market Change Percent | -0.5076137 |
| Regular Market Day High | 1.96 |
| Regular Market Day Low | 1.9232 |
| Regular Market Day Range | 1.9232 - 1.96 |
| Regular Market Open | 1.93 |
| Regular Market Previous Close | 1.97 |
| Regular Market Price | 1.96 |
| Regular Market Time | 1,776,780,891 |
| Regular Market Volume | 10,888 |
| Return On Assets | -0.44092998 |
| Return On Equity | -0.78616995 |
| Revenue Growth | -0.212 |
| Revenue Per Share | 0.008 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 2,959,469 |
| Shares Percent Shares Out | 0.0075 |
| Shares Short | 22,264 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 510,812 |
| Short Name | Cardio Diagnostics Holdings Inc |
| Short Percent Of Float | 0.0075 |
| Short Ratio | 0.04 |
| Source Interval | 15 |
| State | IL |
| Symbol | CDIO |
| Total Cash | 5,110,630 |
| Total Cash Per Share | 1.727 |
| Total Debt | 695,619 |
| Total Revenue | 14,825 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -3.71 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 3.3153 |
| Two Hundred Day Average Change | -1.3553 |
| Two Hundred Day Average Change Percent | -0.40880162 |
| Type Disp | Equity |
| Volume | 10,888 |
| Website | https://cdio.ai |
| Zip | 60,654 |